期刊文献+

维持性血液透析患者凝血因子Ⅻ活性及D-二聚体水平的变化研究 被引量:7

Changes in the Activity of Plasma Coagulation Factor Ⅻ and the Level of D-dimmer in Maintenance Hemodialysis
下载PDF
导出
摘要 目的观察维持性血液透析(MHD)患者血浆凝血因子Ⅻ活性(FⅫ:C)及D-二聚体水平的变化,探讨凝血、纤溶的特点及血液透析过程对其影响。方法分别测定70例MHD患者(MHD组)在透析开始时和结束时的血浆FⅫ:C及D-二聚体水平,并与65例健康体检者(对照组)进行对照。结果透析前MHD组患者的血浆FⅫ:C水平为(127.6±37.2)%,高于对照组的(90.0±12.0)%,差异有统计学意义(t=5.52,P<0.01);透析结束时MHD组患者的血浆FⅫ:C水平为(84.3±19.7)%,低于透析前的水平,差异有统计学意义(t=7.58,P<0.01)。透析前MHD组患者的血浆D-二聚体水平为(1.09±1.07)mg/L,高于对照组的(0.35±0.09)mg/L,差异有统计学意义(t=4.11,P<0.01);透析结束时MHD组患者的血浆D-二聚体水平为(1.23±1.19)mg/L,高于透析前的水平,差异有统计学意义(t=7.50,P<0.01)。结论 MHD患者存在着高凝及继发纤溶状态,血液透析过程使其更加明显;血浆D-二聚体水平升高提示高凝继发纤溶存在;MHD患者FⅫ:C明显升高,血液透析过程会使血浆FⅫ:C下降。 Objective To investigate the effects of maintenance hemodialysis on fibrinolysis and coagulation.system through observing changes in the activity of plasma coagulation factor Ⅻ activity(FⅫ:C)as well as the level of D-dimmer in patients undergoing maintenance hemodialysis(MHD).Methods Pre-and post-hemodialysis(HD)levels of plasma FⅫ:C and D-dimmer were determined in 70 MHD patients(MHD group),and the results were compared with those in 65 healthy subjects(the control group).Results The Pre-HD levels of plasma FⅫ:C and D-dimmer were significantly higher in MHD group than in control group((127.6±37.2)% vs(90.0±12.0)% and(1.09±1.07)mg/L vs(0.35±0.09)mg/L,respectively)(P0.01).The plasma FⅫ:C significantly decreased after HD((84.3±19.7)% vs(127.6±37.2)%)(P0.01),and the plasma D-dimmer significantly increased after HD((1.23±1.19)mg/L vs(1.09±1.07)mg/L)(P0.01).Conclution The increased plasma D-dimmer level after HD suggests that HD aggravate the hyperfibrinolysis secondary to the hypercoagulable state in MHD patients.The level of plasmaFⅫ:C rises,in MHD patients,and decreases after HD.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第11期1208-1210,共3页 Chinese General Practice
关键词 肾透析 凝血因子Ⅻ D-二聚体 Renal dialysis Coagulation factor Ⅻ D-dimmer
  • 相关文献

参考文献5

二级参考文献33

  • 1Mary E,Eberst MD,Lee R, et al .Hemostasis in renal diseases: Pathophysiology and Management[J]. Am J Med, 1994,96:168.
  • 2Zachee P, Vermylen J. Boogaerts MA. Hematologic aspects of end-stage renal failure[J] .Ann Hematol, 1994,69:33.
  • 3Vigano G,Benigni A,Mendogni D. Recombinant human ery thropoietin to correct uremic bleeding[J] .Am J kidney, 1991,18:44.
  • 4Liani M, Salvati F, Tresca E, et al .Bleeding diathesis is uremic patients treated with peritoreal dialysis:role ofplatelet glycoproteins GP Ⅰ b and GP Ⅰ b/Ⅲ a abnormalities[J]. Nephron, 1996,74:234.
  • 5Benigni A,Boccardo P, Galbusera M, et al .Reversible ac tivation defect of the platelet glycoprotein GP Ⅱ b- Ⅲ a a complex in patients with uremia[J] .Am J Kidney,1993,22(5):668.
  • 6Gianluigi V. Bleeding and coagulation abnormalities[ M]. In: Massry SG, Glassock RG, Textbook of nephrology. 3th ed. Bultimore Maryland: Williams & Willines, 1995.1373.
  • 7akamura Y,Tomura S,Tachibana K, et al .Enhanced fibrinolytic activity during the course of hemodialysis[J]. Cln Nephrol,1992,38:90.
  • 8shii Y,Yano S,Kanai H, et al.Evaluation of blood coagulation-fibrinolysis system in patients receiving chronic hemodialysis[J]. Nephron, 1996,73:407.
  • 9Kaufman AM, Godmere RO, Levin NW. Dialyzer reuse[M]. In: Daugirdas JT, IngTS(eds). Handbook of Dialysis(edz)Boston MA Little Brown,1994.137.
  • 10李明喜.慢性肾衰出血倾向的发病机理和治疗[J].国外医学(泌尿系统分册),1997,17(3):100-103. 被引量:7

共引文献21

同被引文献65

引证文献7

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部